Skip to main content

CVE detail

CVE-2007-2391

Cross-site scripting (XSS) vulnerability in Apple Safari Beta 3.0.1 for Windows allows remote attackers to inject arbitrary web script or HTML via a web page that includes a windows.setTimeout function that is activated after the user has moved from the current page.

CVSS 4.3 · MediumBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • The Safari 3 Public Beta was released on June 11 for Mac OS X and Windows XP/Vista. Soon afterwards security researchers found some security vulnerabilities in the initial release of the Windows XP/Vista version of the software. Safari 3.0.1 Public Beta for Windows is now available and addresses the following issues in Safari 3 Public Beta: CVE-ID: CVE-2007-3186 Impact: Visiting a malicious website may lead to arbitrary code execution Description: A command injection vulnerability exists … More →

    newswww.helpnetsecurity.comJun 14, 2007, 2:43 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence